336 related articles for article (PubMed ID: 17961973)
21. Transcriptomics-based identification of developmental toxicants through their interference with cardiomyocyte differentiation of embryonic stem cells.
van Dartel DA; Pennings JL; van Schooten FJ; Piersma AH
Toxicol Appl Pharmacol; 2010 Mar; 243(3):420-8. PubMed ID: 20036270
[TBL] [Abstract][Full Text] [Related]
22. Specific effect of 5-fluorouracil on alpha-fetoprotein gene expression during the in vitro mouse embryonic stem cell differentiation.
Pamies D; Vicente-Salar N; Sogorb MA; Roche E; Reig JA
Int J Toxicol; 2010; 29(3):297-304. PubMed ID: 20448262
[TBL] [Abstract][Full Text] [Related]
23. [Embryonic stem cell test in screening of medicine and other chemicals].
Zhao Q; Xu J
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2005 Feb; 22(1):181-4. PubMed ID: 15762145
[TBL] [Abstract][Full Text] [Related]
24. [Study on the validation of application model on embryonic stem test].
Yu Z; Yan W; Zhang L; Xu H
Wei Sheng Yan Jiu; 2008 Sep; 37(5):570-3. PubMed ID: 19069656
[TBL] [Abstract][Full Text] [Related]
25. [Improving the embryonic stem cell test (EST) by establishing molecular endpoints of tissue specific development using murine embryonic stem cells (D3 cells)].
Seiler A; Visan A; Pohl I; Genschow E; Buesen R; Spielmann H
ALTEX; 2002; 19 Suppl 1():55-63. PubMed ID: 12096331
[TBL] [Abstract][Full Text] [Related]
26. Optimisation of the cell cultivation methods in the embryonic stem cell test results in an increased differentiation potential of the cells into strong beating myocard cells.
De Smedt A; Steemans M; De Boeck M; Peters AK; van der Leede BJ; Van Goethem F; Lampo A; Vanparys P
Toxicol In Vitro; 2008 Oct; 22(7):1789-96. PubMed ID: 18672049
[TBL] [Abstract][Full Text] [Related]
27. Assessment of the Embryonic Stem Cell Test and application and use in the pharmaceutical industry.
Paquette JA; Kumpf SW; Streck RD; Thomson JJ; Chapin RE; Stedman DB
Birth Defects Res B Dev Reprod Toxicol; 2008 Apr; 83(2):104-11. PubMed ID: 18361453
[TBL] [Abstract][Full Text] [Related]
28. Use of two validated in vitro tests to assess the embryotoxic potential of mycophenolic acid.
Eckardt K; Stahlmann R
Arch Toxicol; 2010 Jan; 84(1):37-43. PubMed ID: 19856175
[TBL] [Abstract][Full Text] [Related]
29. In vitro developmental toxicity test detects inhibition of stem cell differentiation by silica nanoparticles.
Park MV; Annema W; Salvati A; Lesniak A; Elsaesser A; Barnes C; McKerr G; Howard CV; Lynch I; Dawson KA; Piersma AH; de Jong WH
Toxicol Appl Pharmacol; 2009 Oct; 240(1):108-16. PubMed ID: 19631676
[TBL] [Abstract][Full Text] [Related]
30. [Establishment of embryonic stem cell for evaluation of development neurotoxicity and test the validation of embryonic stem cell].
Yu Z; Xu H
Wei Sheng Yan Jiu; 2010 Nov; 39(6):685-8. PubMed ID: 21351631
[TBL] [Abstract][Full Text] [Related]
31. Defined culture medium for stem cell differentiation: applicability of serum-free conditions in the mouse embryonic stem cell test.
Riebeling C; Schlechter K; Buesen R; Spielmann H; Luch A; Seiler A
Toxicol In Vitro; 2011 Jun; 25(4):914-21. PubMed ID: 21376803
[TBL] [Abstract][Full Text] [Related]
32. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
33. Development of a neural teratogenicity test based on human embryonic stem cells: response to retinoic acid exposure.
Colleoni S; Galli C; Gaspar JA; Meganathan K; Jagtap S; Hescheler J; Sachinidis A; Lazzari G
Toxicol Sci; 2011 Dec; 124(2):370-7. PubMed ID: 21934132
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of hepatotoxicity of chemicals using hepatic progenitor and hepatocyte-like cells derived from mouse embryonic stem cells: effect of chemicals on ESC-derived hepatocyte differentiation.
Kang SJ; Jeong SH; Kim EJ; Cho JH; Park YI; Park SW; Shin HS; Son SW; Kang HG
Cell Biol Toxicol; 2013 Feb; 29(1):1-11. PubMed ID: 23108452
[TBL] [Abstract][Full Text] [Related]
35. Metabolic activation capacity by primary hepatocytes expands the applicability of the embryonic stem cell test as alternative to experimental animal testing.
Hettwer M; Reis-Fernandes MA; Iken M; Ott M; Steinberg P; Nau H
Reprod Toxicol; 2010 Aug; 30(1):113-20. PubMed ID: 20132877
[TBL] [Abstract][Full Text] [Related]
36. Hand1-Luc embryonic stem cell test (Hand1-Luc EST): a novel rapid and highly reproducible in vitro test for embryotoxicity by measuring cytotoxicity and differentiation toxicity using engineered mouse ES cells.
Le Coz F; Suzuki N; Nagahori H; Omori T; Saito K
J Toxicol Sci; 2015 Apr; 40(2):251-61. PubMed ID: 25786529
[TBL] [Abstract][Full Text] [Related]
37. Establishment and assessment of a new human embryonic stem cell-based biomarker assay for developmental toxicity screening.
Palmer JA; Smith AM; Egnash LA; Conard KR; West PR; Burrier RE; Donley EL; Kirchner FR
Birth Defects Res B Dev Reprod Toxicol; 2013 Aug; 98(4):343-63. PubMed ID: 24123775
[TBL] [Abstract][Full Text] [Related]
38. Assessment of drug induced developmental toxicity using human embryonic stem cells.
Mehta A; Konala VB; Khanna A; Majumdar AS
Cell Biol Int; 2008 Nov; 32(11):1412-24. PubMed ID: 18778783
[TBL] [Abstract][Full Text] [Related]
39. P19 neuronal differentiation and retinoic acid metabolism as criteria to investigate atrazine, nitrite, and nitrate developmental toxicity.
Solari M; Paquin J; Ducharme P; Boily M
Toxicol Sci; 2010 Jan; 113(1):116-26. PubMed ID: 19808863
[TBL] [Abstract][Full Text] [Related]
40. Unexpected common mechanistic pathways for embryotoxicity of warfarin and lovastatin.
Groebe K; Hayess K; Klemm-Manns M; Schwall G; Wozny W; Steemans M; Peters AK; Sastri C; Jaeckel P; Stegmann W; Zengerling H; Schöpf R; Poznanovic S; Stummann TC; Seiler A; Spielmann H; Schrattenholz A
Reprod Toxicol; 2010 Aug; 30(1):121-30. PubMed ID: 20493250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
